Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution.

BMI, body mass index Breast Neoplasm Breath-hold DIBH, deep inspiration breath-hold Female FiO2, fraction of inspired oxygen HFNO, high flow nasal oxygen HFPV, high Frequency Percussive Ventilation Hyperventilation IMRT, intensity modulated radiotherapy L-DIBH, prolonged deep inspiration breath-hold Oxygen Prone RR, respiratory rate Radiotherapy

Journal

Clinical and translational radiation oncology
ISSN: 2405-6308
Titre abrégé: Clin Transl Radiat Oncol
Pays: Ireland
ID NLM: 101713416

Informations de publication

Date de publication:
May 2021
Historique:
received: 26 11 2020
revised: 17 02 2021
accepted: 17 02 2021
entrez: 18 3 2021
pubmed: 19 3 2021
medline: 19 3 2021
Statut: epublish

Résumé

Deep inspiration breath-hold is an established technique to reduce heart dose during breast cancer radiotherapy. However, modern breast cancer radiotherapy techniques with lymph node irradiation often require long beam-on times of up to 5 min. Therefore, the combination with deep inspiration breath-hold (DIBH) becomes challenging. A simple support technique for longer duration deep inspiration breath-hold (L-DIBH), feasible for daily use at the radiotherapy department, is required to maximize heart sparing. At our department, a new protocol for multiple L-DIBH of at least 2 min and 30 s was developed on 32 healthy volunteers and validated on 8 breast cancer patients during radiotherapy treatment, using a pragmatic process of iterative development, including all major stakeholders. Each participant performed 12 L-DIBHs, on 4 different days. Different methods of pre-oxygenation and voluntary hyperventilation were tested, and scored on L-DIBH duration, ease of use, and comfort. Based on 384 L-DIBHs from 32 healthy volunteers, voluntary hyperventilation for 3 min whilst receiving high-flow nasal oxygen at 40 L/min was the most promising technique. During validation, the median L-DIBH duration in prone position of 8 breast cancer patients improved from 59 s without support to 3 min and 9 s using the technique (p < 0.001). A new and simple L-DIBH protocol was developed feasible for daily use at the radiotherapy center.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Deep inspiration breath-hold is an established technique to reduce heart dose during breast cancer radiotherapy. However, modern breast cancer radiotherapy techniques with lymph node irradiation often require long beam-on times of up to 5 min. Therefore, the combination with deep inspiration breath-hold (DIBH) becomes challenging. A simple support technique for longer duration deep inspiration breath-hold (L-DIBH), feasible for daily use at the radiotherapy department, is required to maximize heart sparing.
MATERIALS AND METHODS METHODS
At our department, a new protocol for multiple L-DIBH of at least 2 min and 30 s was developed on 32 healthy volunteers and validated on 8 breast cancer patients during radiotherapy treatment, using a pragmatic process of iterative development, including all major stakeholders. Each participant performed 12 L-DIBHs, on 4 different days. Different methods of pre-oxygenation and voluntary hyperventilation were tested, and scored on L-DIBH duration, ease of use, and comfort.
RESULTS RESULTS
Based on 384 L-DIBHs from 32 healthy volunteers, voluntary hyperventilation for 3 min whilst receiving high-flow nasal oxygen at 40 L/min was the most promising technique. During validation, the median L-DIBH duration in prone position of 8 breast cancer patients improved from 59 s without support to 3 min and 9 s using the technique (p < 0.001).
CONCLUSION CONCLUSIONS
A new and simple L-DIBH protocol was developed feasible for daily use at the radiotherapy center.

Identifiants

pubmed: 33732910
doi: 10.1016/j.ctro.2021.02.007
pii: S2405-6308(21)00021-5
pmc: PMC7941008
doi:

Types de publication

Journal Article

Langues

eng

Pagination

10-16

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Radiother Oncol. 2016 Feb;118(2):220-6
pubmed: 26979264
Radiother Oncol. 2019 Apr;133:132-139
pubmed: 30935569
Radiother Oncol. 2013 Aug;108(2):203-8
pubmed: 24044803
Radiother Oncol. 2010 Aug;96(2):178-84
pubmed: 20561695
BMC Anesthesiol. 2014 Aug 07;14:66
pubmed: 25110463
Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):267-72
pubmed: 17448879
Radiother Oncol. 2013 Aug;108(2):242-7
pubmed: 23726115
Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1484-95
pubmed: 18035211
Radiother Oncol. 2019 Dec;141:296-303
pubmed: 31540744
N Engl J Med. 1995 Nov 30;333(22):1444-55
pubmed: 7477144
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):478-92
pubmed: 26867877
Lancet. 2011 Nov 12;378(9804):1707-16
pubmed: 22019144
Pract Radiat Oncol. 2018 May - Jun;8(3):145-152
pubmed: 29545124
Anesth Analg. 2020 Mar;130(3):715-724
pubmed: 30633057
Br J Anaesth. 2015 Dec;115(6):827-48
pubmed: 26556848
Acta Anaesthesiol Scand. 2011 Jan;55(1):75-81
pubmed: 21039356
J Appl Physiol. 1961 Jul;16:583-6
pubmed: 13696183
Acta Oncol. 2013 Oct;52(7):1458-63
pubmed: 23957594
Phys Med Biol. 2009 Nov 21;54(22):6853-65
pubmed: 19864703
Anaesthesia. 1983 Feb;38(2):96-102
pubmed: 6402951
Radiother Oncol. 2016 Jan;118(1):194-8
pubmed: 26709069
J Med Radiat Sci. 2015 Mar;62(1):66-73
pubmed: 26229669
Med Dosim. 2017 Autumn;42(3):177-184
pubmed: 28526193
Radiother Oncol. 2015 Dec;117(3):473-6
pubmed: 26455452
Med Dosim. 2019 Winter;44(4):e13-e18
pubmed: 30529304
Clin Oncol (R Coll Radiol). 2018 Sep;30(9):571-577
pubmed: 29773446
Clin Oncol (R Coll Radiol). 2017 Mar;29(3):e51-e56
pubmed: 27890346
Radiother Oncol. 2019 Dec;141:283-291
pubmed: 31653574
Radiother Oncol. 2011 Aug;100(2):231-5
pubmed: 21497926
Br J Radiol. 2016 Jul;89(1063):20160194
pubmed: 27168468
Front Oncol. 2018 Apr 04;8:87
pubmed: 29670854
Tech Innov Patient Support Radiat Oncol. 2018 Dec 14;9:8-12
pubmed: 32095589
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):902-9
pubmed: 22494590
J Med Imaging Radiat Oncol. 2018 Dec;62(6):854-860
pubmed: 30175890
Br J Radiol. 2016 Jun;89(1062):20150741
pubmed: 26959610
Radiother Oncol. 2007 Mar;82(3):337-40
pubmed: 16978722
Lung. 1983;161(5):257-73
pubmed: 6138480
J Appl Physiol (1985). 2009 Jan;106(1):284-92
pubmed: 18974367
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
Exp Physiol. 2006 Jan;91(1):1-15
pubmed: 16272264
Radiother Oncol. 2015 Jan;114(1):79-84
pubmed: 25497557

Auteurs

Vincent Vakaet (V)

Department of Human Structure and Repair, Ghent University, Belgium.
Department of Radiation Oncology, Ghent University Hospital, Belgium.

Hans Van Hulle (H)

Department of Human Structure and Repair, Ghent University, Belgium.

Max Schoepen (M)

Department of Human Structure and Repair, Ghent University, Belgium.
Department of Industrial Systems Engineering and Product Design, Kortrijk, Belgium.

Els Van Caelenberg (E)

Department of Anesthesia, Ghent University Hospital, Belgium.

Annick Van Greveling (A)

Department of Radiation Oncology, Ghent University Hospital, Belgium.

Jeroen Holvoet (J)

Department of Radiation Oncology, Ghent University Hospital, Belgium.

Chris Monten (C)

Department of Human Structure and Repair, Ghent University, Belgium.
Department of Radiation Oncology, Ghent University Hospital, Belgium.

Luc De Baerdemaeker (L)

Department of Anesthesia, Ghent University Hospital, Belgium.
Department of Basic and Applied Medical Sciences, Ghent University, Belgium.

Wilfried De Neve (W)

Department of Human Structure and Repair, Ghent University, Belgium.
Department of Radiation Oncology, Ghent University Hospital, Belgium.

Marc Coppens (M)

Department of Anesthesia, Ghent University Hospital, Belgium.
Department of Basic and Applied Medical Sciences, Ghent University, Belgium.

Liv Veldeman (L)

Department of Human Structure and Repair, Ghent University, Belgium.
Department of Radiation Oncology, Ghent University Hospital, Belgium.

Classifications MeSH